Author:
Kiem Hans-Peter,Baum Christopher,Bushman Frederic D,Byrne Barry J,Carter Barrie J,Cavagnaro Joy,Malech Harry L,Mendell Jerry R,Naldini Luigi M,Sorrentino Brian P,Williams David A,Flotte Terence R
Subject
Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine
Reference16 articles.
1. Not reinventing the wheel: applying the 3Rs concepts to viral vector gene therapy biodistribution studies;MacLachlan;Hum Gene Ther,2013
2. Preclinical toxicology and biodistribution studies of recombinant adeno-associated virus 1 human acid alpha-glucosidase;Conlon;Hum Gene Ther,2013
3. Preclinical characterization of a recombinant adeno-associated virus type 1–pseudotyped vector demonstrates dose-dependent injection site inflammation and dissemination of vector genomes to distant sites;Flotte;Hum Gene Ther,2007
4. Expediting drug development—the FDA's new “breakthrough therapy” designation;Sherman;N Engl J Med,2013
5. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease;Cavazzana-Calvo;Science,2000
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献